4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[3-(2-methylpiperidin-1-yl)propyl]benzamide
Chemical Structure Depiction of
4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[3-(2-methylpiperidin-1-yl)propyl]benzamide
4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[3-(2-methylpiperidin-1-yl)propyl]benzamide
Compound characteristics
Compound ID: | L610-0141 |
Compound Name: | 4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[3-(2-methylpiperidin-1-yl)propyl]benzamide |
Molecular Weight: | 488.63 |
Molecular Formula: | C29 H36 N4 O3 |
Smiles: | CC1CCCCN1CCCNC(c1ccc(CN2C(C3CCCN3C(c3ccccc23)=O)=O)cc1)=O |
Stereo: | MIXTURE OF STEREOISOMERS |
logP: | 2.0933 |
logD: | -0.7551 |
logSw: | -2.9916 |
Hydrogen bond acceptors count: | 7 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 59.961 |
InChI Key: | MIESAWWGTXONOP-UHFFFAOYSA-N |